Navigation Links
Mtech Announces Finalists for University of Maryland $75K Business Plan Competition
Date:4/6/2011

COLLEGE PARK, Md., April 6, 2011 /PRNewswire-USNewswire/ -- The Maryland Technology Enterprise Institute (Mtech) today announces eight finalists for the University of Maryland $75K Business Plan Competition. Now in its eleventh year, the competition has served as a launch pad for Inc. 500 and additional multi-million-dollar companies.

(Logo: http://photos.prnewswire.com/prnh/20101005/MTECHLOGO)

Finalists were selected among 20 semi-finalists and 71 initial entries in the categories of high-technology/biotechnology and undergraduate students. Entries, submitted as full business plans, were advanced based upon their value proposition, competitive advantage, target market, business model, intellectual property, and clarity.

Finalists will present their companies during the University of Maryland $75K Business Plan Competition finals, held on May 6, to a panel of judges from the regional venture-building community before a live audience at the Stamp Student Union.

Finalists include:

High-Technology/Biotechnology Category

  • HemeCentric Inc. is developing valuable products in nutrition, healthcare, and agriculture based on groundbreaking discoveries in heme biology and iron regulation. Team: Iqbal Hamza, assistant professor, animal and avian sciences; Gregory J. Feulner; Steven L. Hubert.
  • Ibis Microtech equips medical professionals, food quality control technicians, first responders, and national defense agencies with cost-effective diagnostics devices capable of performing laboratory-grade analyses on-site, and in record time. Team: Pamela Abshire, associate professor, electrical and computer engineering; Marc Dandin, doctoral student, bioengineering; Marc Cohen, assistant research scientist, Institute for Systems Research; David Sand
    '/>"/>

SOURCE Maryland Technology Enterprise Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data on DermTechs Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology
2. Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development
3. Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
4. Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine
5. Immtech Announces Posting of Annual Shareholders Meeting Presentation
6. Immtech Reports Fiscal Second Quarter 2008 Results
7. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
8. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
9. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
10. Chinese SFDA Grants Immtech Fast Track Status
11. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... ALBANY, New York , August 20, 2014 /PRNewswire/ ... published a new market report titled "Monochloroacetic Acid (MCA) ... Other Applications - Global Industry Analysis, Size, Share, Growth, ... acid market was valued at USD 817.1 million in ... by 2020, growing at a CAGR of 3.6% during ...
(Date:8/20/2014)... , Aug. 20, 2014 ... of the "Global Advanced Wound Care and ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020" report to their offering. ... advanced wound care and closure market (types, applications, ...
(Date:8/20/2014)... 2014  Decision Resources Group finds that ... device market will expand through 2023 as ... fibrillation (AF). The increasing acceptance of ablation ... will spur adoption of premium-priced products designed ... loop diagnostic catheters, cryoablation catheters and contact ...
Breaking Medicine Technology:Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3
... Services, Inc. (NYSE: WST ) announced today that it ... opens on Tuesday, November 3, 2009 and will follow with ... at 9:00 a.m. Eastern Time. To participate on the call ... A live broadcast of the conference call will be available ...
... Inc. (NYSE: HSP ), a leading global specialty ... the third quarter ended Sept. 30, 2009. Net sales ... earnings per share were $0.90. (Adjusted* measures exclude certain ... and the attached schedules.) , "Hospira delivered strong results ...
Cached Medicine Technology:West to Host 2009 Third Quarter Conference Call 2Hospira Reports Third-Quarter 2009 Results 2Hospira Reports Third-Quarter 2009 Results 3Hospira Reports Third-Quarter 2009 Results 4Hospira Reports Third-Quarter 2009 Results 5Hospira Reports Third-Quarter 2009 Results 6Hospira Reports Third-Quarter 2009 Results 7Hospira Reports Third-Quarter 2009 Results 8Hospira Reports Third-Quarter 2009 Results 9Hospira Reports Third-Quarter 2009 Results 10Hospira Reports Third-Quarter 2009 Results 11Hospira Reports Third-Quarter 2009 Results 12Hospira Reports Third-Quarter 2009 Results 13Hospira Reports Third-Quarter 2009 Results 14Hospira Reports Third-Quarter 2009 Results 15Hospira Reports Third-Quarter 2009 Results 16Hospira Reports Third-Quarter 2009 Results 17Hospira Reports Third-Quarter 2009 Results 18Hospira Reports Third-Quarter 2009 Results 19Hospira Reports Third-Quarter 2009 Results 20Hospira Reports Third-Quarter 2009 Results 21Hospira Reports Third-Quarter 2009 Results 22Hospira Reports Third-Quarter 2009 Results 23Hospira Reports Third-Quarter 2009 Results 24Hospira Reports Third-Quarter 2009 Results 25Hospira Reports Third-Quarter 2009 Results 26Hospira Reports Third-Quarter 2009 Results 27Hospira Reports Third-Quarter 2009 Results 28
(Date:8/20/2014)... Line: A study in Australia examined patient and ... (a marker of tumor cell growth) in an ... cancer in patients. , Author: ... Victoria, Australia, and colleagues. , Background: The ... cell division) has been connected with prognosis and ...
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 Hundreds ... on behalf of women who were allegedly injured due ... forward in New Jersey’s Bergen County Superior Court, Bernstein ... issued on August 15, 2014, the Court has established ... for Mirena lawsuits that are part of the proceeding’s ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... cells grow may help doctors diagnose and treat the most ... have found that the deadliest skin cancers occur most often ... long history of sun exposure. These lesions also grow ... cell growth -- called "high mitotic rate" -- is ...
(Date:8/20/2014)... Aug. 20, 2014 A common approach to treating ... did not improve survival chances for people who suddenly ... at the University of Pittsburgh School of Medicine. , ... One , suggest acute hemodialysis, an aggressive method that ... may not provide a definitive benefit to the patient. ...
(Date:8/20/2014)... Research from Columbia University Medical Center shows that nerves ... and that blocking nerve signals using surgery or Botox ... The study was conducted by the laboratory of Timothy ... PhD, in Norway and is published in today,s issue ... long observed that human and mouse cancers contain a ...
Breaking Medicine News(10 mins):Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Severing nerves may shrink stomach cancers: Botox injections slow growth of tumors in mice 2
... Schweitzer (Chair of the Democratic Governors Association) and Maryland ... applauded President Obama,s reported selection of former DGA Chair ... Services. "Our health care system is broken, and Governor ... effort to fix it," Governor Schweitzer said. "In reforming ...
... rare, orphan and neglected diseases, launches iWish, which allows people to ... diseases through and image. In addition, people are invited to explain ... solutions for a rare disease or for the community in general. ... ...
... research presented at the 2009 American Orthopaedic Society of ... elbow ulnar collateral ligament (UCL) reconstruction prior to selection ... increase the risk of future injury or affect the ... no statistical difference between athletes who had undergone UCL ...
... Communication Service introduces vSling for capturing and distributing ... Smile Reminder will highlight their newest practice-to-patient ... Society Midwinter Meeting. Attracting thousands of dental practitioners ... platform for Smile Reminder to show its revenue ...
... experts urge better awareness of how machines work , , ... clearing the sidewalk quicker and easier, but those who ... with hand injuries and accidental amputations, say medical experts. ... not the type of injuries that can be reconstructed," ...
... 27 LCA-Vision Inc. (Nasdaq: LCAV ) ... independent research and proxy advisory firm, today recommended that ... of Directors and reject all of the proposals, including ... replacement Directors, in the Joffe Group,s consent solicitation. ...
Cached Medicine News:Health News:CheckOrphan Launches iWish to Commemorate Rare Disease Day 2Health News:CheckOrphan Launches iWish to Commemorate Rare Disease Day 3Health News:Elbow ligament reconstruction appears not to effect future professional advancement in baseball 2Health News:Smile Reminder Showcases Viral Marketing Tool at Chicago Dental Society's Midwinter Meeting 2Health News:Smile Reminder Showcases Viral Marketing Tool at Chicago Dental Society's Midwinter Meeting 3Health News:Snowblower Hand Injuries Often Extensive, Study Finds 2Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 2Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 3Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: